Anthem Blue Cross Blue Shield of Colorado prior authorization, page 42

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
81289FXN (frataxin) (eg, Friedreich ataxia) gene analysis; known familial variant(s)Colorado Prior Authorization List, Pg 100 Original policy
81290Mcoln1 (Mucolipin 1) (Eg, Mucolipidosis, Type Iv) Gene Analysis, Common Variants (Eg, Ivs3-2A>G, Del6.4Kb)Colorado Prior Authorization List, Pg 100 Original policy
81291Mthfr (5,10-Methylenetetrahydrofolate Reductase) (Eg, Hereditary Hypercoagulability) Gene Analysis, Common Variants (Eg, 677T, 1298C)Colorado Prior Authorization List, Pg 100 Original policy
81292Mlh1 (Mutl Homolog 1, Colon Cancer, Nonpolyposis Type 2) (Eg, Hereditary Non- Polyposis Colorectal Cancer, Lynch Syndrome) Gene Analysis; Full Sequence AnalysisColorado Prior Authorization List, Pg 100 Original policy
81293Mlh1 (Mutl Homolog 1, Colon Cancer, Nonpolyposis Type 2) (Eg, Hereditary Non- Polyposis Colorectal Cancer, Lynch Syndrome) Gene Analysis; Known Familial VariantsColorado Prior Authorization List, Pg 100 Original policy
81294Mlh1 (Mutl Homolog 1, Colon Cancer, Nonpolyposis Type 2) (Eg, Hereditary Non- Polyposis Colorectal Cancer, Lynch Syndrome) Gene Analysis; Duplication/Deletion VariantsColorado Prior Authorization List, Pg 100 Original policy
81295Msh2 (Muts Homolog 2, Colon Cancer, Nonpolyposis Type 1) (Eg, Hereditary Non-Polyposis Colorectal Cancer, Lynch Syndrome) Gene Analysis; Full Sequence AnalysisColorado Prior Authorization List, Pg 100 Original policy
81296Msh2 (Muts Homolog 2, Colon Cancer, Nonpolyposis Type 1) (Eg, Hereditary Non-Polyposis Colorectal Cancer, Lynch Syndrome) Gene Analysis; Known Familial VariantsColorado Prior Authorization List, Pg 100 Original policy
81297Msh2 (Muts Homolog 2, Colon Cancer, Nonpolyposis Type 1) (Eg, Hereditary Non-Polyposis Colorectal Cancer, Lynch Syndrome) Gene Analysis; Duplication/Deletion VariantsColorado Prior Authorization List, Pg 100 Original policy
81298Msh6 (Muts Homolog 6 [E. Coli]) (Eg, Hereditary Non-Polyposis Colorectal Cancer, Lynch Syndrome) Gene Analysis; Full Sequence AnalysisColorado Prior Authorization List, Pg 100 Original policy
81299Msh6 (Muts Homolog 6 [E. Coli]) (Eg, Hereditary Non-Polyposis Colorectal Cancer, Lynch Syndrome) Gene Analysis; Known Familial VariantsColorado Prior Authorization List, Pg 100 Original policy
81300Msh6 (Muts Homolog 6 [E. Coli]) (Eg, Hereditary Non-Polyposis Colorectal Cancer, Lynch Syndrome) Gene Analysis; Duplication/Deletion VariantsColorado Prior Authorization List, Pg 100 Original policy
81301Microsatellite Instability Analysis (Eg, Hereditary Non-Polyposis Colorectal Cancer, Lynch Syndrome) Of Markers For Mismatch Repair Deficiency (Eg, Bat25, Bat26), Includes ComColorado Prior Authorization List, Pg 100 Original policy
81302Mecp2 (Methyl Cpg Binding Protein 2) (Eg, Rett Syndrome) Gene Analysis; Full Sequence AnalysisColorado Prior Authorization List, Pg 100 Original policy
81303Mecp2 (Methyl Cpg Binding Protein 2) (Eg, Rett Syndrome) Gene Analysis; Known Familial VariantColorado Prior Authorization List, Pg 100 Original policy
81304Mecp2 (Methyl Cpg Binding Protein 2) (Eg, Rett Syndrome) Gene Analysis; Duplication/Deletion VariantsColorado Prior Authorization List, Pg 100 Original policy
81305MYD88 (myeloid differentiation primary response 88) (eg, Waldenstrom's macroglobulinemia, lymphoplasmacytic leukemia) gene analysis, p.Leu265Pro (L265P) variantColorado Prior Authorization List, Pg 100 Original policy
81306NUDT15 (nudix hydrolase 15) (eg, drug metabolism) gene analysis, common variant(s) (eg, *2, *3, *4, *5, *6)Colorado Prior Authorization List, Pg 100 Original policy
81307PALB2 (partner and localizer of BRCA2) (eg, breast and pancreatic cancer) gene analysis; full gene sequenceColorado Prior Authorization List, Pg 100 Original policy
81308PALB2 (partner and localizer of BRCA2) (eg, breast and pancreatic cancer) gene analysis; known familial variantColorado Prior Authorization List, Pg 100 Original policy
81309PIK3CA (phosphatidylinositol-4, 5-biphosphate 3-kinase, catalytic subunit alpha) (eg, colorectal and breast cancer) gene analysis, targeted sequence analysis (eg, exons 7, 9Colorado Prior Authorization List, Pg 101 Original policy
81310Npm1 (Nucleophosmin) (Eg, Acute Myeloid Leukemia) Gene Analysis, Exon 12 VariantsColorado Prior Authorization List, Pg 101 Original policy
81311NRAS (neuroblastoma RAS viral [v-ras] oncogene homolog) (eg, colorectal carcinoma), gene analysis, variants in exon 2 (eg, codons 12 and 13) and exon 3 (eg, codon 61)Colorado Prior Authorization List, Pg 101 Original policy
81312PABPN1 (poly[A] binding protein nuclear 1) (eg, oculopharyngeal muscular dystrophy) gene analysis, evaluation to detect abnormal (eg, expanded) allelesColorado Prior Authorization List, Pg 101 Original policy
81313PCA3/KLK3 (prostate cancer antigen 3 [non-protein coding]/kallikrein-related peptidase 3 [prostate specific antigen]) ratio (eg, prostate cancer)Colorado Prior Authorization List, Pg 101 Original policy
81314PDGFRA (platelet-derived growth factor receptor, alpha polypeptide) (eg, gastrointestinal stromal tumor [GIST]), gene analysis, targeted sequence analysis (eg, exons 12, 18)Colorado Prior Authorization List, Pg 101 Original policy
81315Pml/Raralpha, (T(15;17)), (Promyelocytic Leukemia/Retinoic Acid Receptor Alpha) (Eg, Promyelocytic Leukemia) Translocation Analysis; Common Breakpoints (Eg, Intron 3 And IntroColorado Prior Authorization List, Pg 101 Original policy
81316Pml/Raralpha, (T(15;17)), (Promyelocytic Leukemia/Retinoic Acid Receptor Alpha) (Eg, Promyelocytic Leukemia) Translocation Analysis; Single Breakpoint (Eg, Intron 3, Intron 6Colorado Prior Authorization List, Pg 101 Original policy
81317Pms2 (Postmeiotic Segregation Increased 2 [S. Cerevisiae]) (Eg, Hereditary Non- Polyposis Colorectal Cancer, Lynch Syndrome) Gene Analysis; Full Sequence AnalysisColorado Prior Authorization List, Pg 101 Original policy
81318Pms2 (Postmeiotic Segregation Increased 2 [S. Cerevisiae]) (Eg, Hereditary Non- Polyposis Colorectal Cancer, Lynch Syndrome) Gene Analysis; Known Familial VariantsColorado Prior Authorization List, Pg 101 Original policy
81319Pms2 (Postmeiotic Segregation Increased 2 [S. Cerevisiae]) (Eg, Hereditary Non- Polyposis Colorectal Cancer, Lynch Syndrome) Gene Analysis; Duplication/Deletion VariantsColorado Prior Authorization List, Pg 101 Original policy
81320PLCG2 (phospholipase C gamma 2) (eg, chronic lymphocytic leukemia) gene analysis, common variants (eg, R665W, S707F, L845F)Colorado Prior Authorization List, Pg 101 Original policy
81321PTEN (phosphatase and tensin homolog) (eg, Cowden syndrome, PTEN hamartoma tumor syndrome) gene analysis; full sequence analysisColorado Prior Authorization List, Pg 101 Original policy
81322PTEN (phosphatase and tensin homolog) (eg, Cowden syndrome, PTEN hamartoma tumor syndrome) gene analysis; known familial variantColorado Prior Authorization List, Pg 101 Original policy
81323PTEN (phosphatase and tensin homolog) (eg, Cowden syndrome, PTEN hamartoma tumor syndrome) gene analysis; duplication/deletion variantColorado Prior Authorization List, Pg 101 Original policy
81324PMP22 (peripheral myelin protein 22) (eg, Charcot-Marie-Tooth, hereditary neuropathy with liability to pressure palsies) gene analysis; duplication/deletion analysisColorado Prior Authorization List, Pg 101 Original policy
81325PMP22 (peripheral myelin protein 22) (eg, Charcot-Marie-Tooth, hereditary neuropathy with liability to pressure palsies) gene analysis; full sequence analysisColorado Prior Authorization List, Pg 101 Original policy
81326PMP22 (peripheral myelin protein 22) (eg, Charcot-Marie-Tooth, hereditary neuropathy with liability to pressure palsies) gene analysis; known familial variantColorado Prior Authorization List, Pg 101 Original policy
81327SEPT9 (Septin9) (eg, colorectal cancer) promoter methylation analysisColorado Prior Authorization List, Pg 101 Original policy
81328SLCO1B1 (solute carrier organic anion transporter family, member 1B1) (eg, adverse drug reaction), gene analysis, common variant(s) (eg, *5)Colorado Prior Authorization List, Pg 101 Original policy
81329SMN1 (survival of motor neuron 1, telomeric) (eg, spinal muscular atrophy) gene analysis; dosage/deletion analysis (eg, carrier testing), includes SMN2 (survival of motor neurColorado Prior Authorization List, Pg 101 Original policy
81330Smpd1(Sphingomyelin Phosphodiesterase 1, Acid Lysosomal) (Eg, Niemann- Pick Disease, Type A) Gene Analysis, Common Variants (Eg, R496L, L302P, Fsp330)Colorado Prior Authorization List, Pg 101 Original policy
81331Snrpn/Ube3A (Small Nuclear Ribonucleoprotein Polypeptide N And Ubiquitin Protein Ligase E3A) (Eg, Prader-Willi Syndrome And/Or Angelman Syndrome), Methylation AnalysisColorado Prior Authorization List, Pg 102 Original policy
81332Serpina1 (Serpin Peptidase Inhibitor, Clade A, Alpha-1 Antiproteinase, Antitrypsin, Member 1) (Eg, Alpha-1-Antitrypsin Deficiency), Gene Analysis, Common Variants (Eg, *S AndColorado Prior Authorization List, Pg 102 Original policy
81333TGFBI (transforming growth factor beta-induced) (eg, corneal dystrophy) gene analysis, common variants (eg, R124H, R124C, R124L, R555W, R555Q)Colorado Prior Authorization List, Pg 102 Original policy
81334RUNX1 (runt related transcription factor 1) (eg, acute myeloid leukemia, familial platelet disorder with associated myeloid malignancy), gene analysis, targeted sequence analyColorado Prior Authorization List, Pg 102 Original policy
81335TPMT (thiopurine S-methyltransferase) (eg, drug metabolism), gene analysis, common variants (eg, *2, *3)Colorado Prior Authorization List, Pg 102 Original policy
81336SMN1 (survival of motor neuron 1, telomeric) (eg, spinal muscular atrophy) gene analysis; full gene sequenceColorado Prior Authorization List, Pg 102 Original policy
81337SMN1 (survival of motor neuron 1, telomeric) (eg, spinal muscular atrophy) gene analysis; known familial sequence variant(s)Colorado Prior Authorization List, Pg 102 Original policy
81338MPL (MPL proto-oncogene, thrombopoietin receptor) (eg, myeloproliferative disorder) gene analysis; common variants (eg, W515A, W515K, W515L, W515R)Colorado Prior Authorization List, Pg 102 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.